Fielder Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$304K Sell
4,868
-464
-9% -$29.3K 0.06% 212
2026
Q2
$307K Sell
5,332
-2,173
-29% -$125K 0.07% 208
2026
Q1
$455K Buy
7,505
+1,736
+30% +$101K 0.1% 134
2025
Q4
$311K Buy
+5,769
New +$278K 0.07% 182

Other funds holding BMY

Fielder Capital Group's BMY Position: Q3 2026 in Review

Fielder Capital Group reduced its Bristol-Myers Squibb (BMY) stake by 8.7% in Q3 2026, selling an estimated $29.3K and leaving 4,868 shares worth $304K. The position accounts for 0.06% of the portfolio, ranked #212.

Fielder Capital Group first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. The position peaked at $455K in Q1 2026. 2,567 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Fielder Capital Group held 4,868 shares of Bristol-Myers Squibb worth $304K as of Q3 2026.
  • Fielder Capital Group sold 464 Bristol-Myers Squibb shares in Q3 2026, an estimated $29.3K.
  • Bristol-Myers Squibb made up 0.06% of Fielder Capital Group's portfolio in Q3 2026, its #212 holding.
  • Fielder Capital Group first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • Fielder Capital Group's Bristol-Myers Squibb position peaked at $455K in Q1 2026.
  • 2,567 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Fielder Capital Group's 13F filing for Q3 2026, filed 12 Nov 2026.